Predictive or non-predictive, prognostic or non-prognostic: Dilemmas generated through small retrospective studies

Por Fakih, Marwan
Publicado em 2010

Targeted therapies in colorectal cancer: the dos, don’ts, and future directions

Por Fakih, Marwan
Publicado em 2013

The International Duration Evaluation of Adjuvant Chemotherapy study: implications for clinical practice

Por Fakih, Marwan
Publicado no J Gastrointest Oncol (2017)

Trastuzumab Plus Pertuzumab Resistance Does Not Preclude Response to Lapatinib Plus Trastuzumab in HER2‐Amplified Colorectal Cancer

Por Fakih, Marwan G.
Publicado no Oncologist (2018)

Impressive response to dual BRAF and MEK inhibition in patients with BRAF mutant intrahepatic cholangiocarcinoma—2 case reports and a brief review

Por Lavingia, Viraj, Fakih, Marwan
Publicado no J Gastrointest Oncol (2016)

The emerging role of neoadjuvant chemotherapy for rectal cancer

Por Boland, Patrick M., Fakih, Marwan
Publicado em 2014

RAS and BRAF in metastatic colorectal cancer management

Por Gong, Jun, Cho, May, Fakih, Marwan
Publicado no J Gastrointest Oncol (2016)

Chemotherapy in patients with hepatobiliary cancers and abnormal hepatic function

Por Gong, Jun, Cho, May, Fakih, Marwan
Publicado no J Gastrointest Oncol (2017)

Complete response to pembrolizumab in a patient with metastatic colon cancer with microsatellite instability and a history of Guillain-Barre syndrome

Por Wang, Chongkai, Sandhu, Jaideep, Fakih, Marwan
Publicado no J Gastrointest Oncol (2019)

A case of class 3 MEK1 mutated metastatic colorectal cancer with a non-durable tumor marker response to MEK and ERK inhibitors

Por Wang, Chongkai, Sandhu, Jaideep, Fakih, Marwan
Publicado no J Gastrointest Oncol (2019)

Targeted therapies in the management of colorectal carcinoma: role of bevacizumab

Por Puthillath, Ajithkumar, Patel, Anush, Fakih, Marwan G
Publicado em 2009

Positron emission tomography as predictor of rectal cancer response during or following neoadjuvant chemoradiation

Por Hopkins, Shane, Fakih, Marwan, Yang, Gary Y
Publicado em 2010

Management of stage II/III rectal cancer

Por Wagner, Timothy D, Fakih, Marwan G, Yang, Gary Y
Publicado em 2010

Molecular profiling of metastatic colorectal tumors using next-generation sequencing: a single-institution experience

Por Gong, Jun, Cho, May, Sy, Marvin, Salgia, Ravi, Fakih, Marwan
Publicado no Oncotarget (2017)

Value-based genomics

Por Gong, Jun, Pan, Kathy, Fakih, Marwan, Pal, Sumanta, Salgia, Ravi
Publicado no Oncotarget (2018)

Integrating Academic and Community Practices in the Management of Colorectal Cancer: The City of Hope Model

Por Karimi, Misagh, Wang, Chongkai, Bahadini, Bahareh, Hajjar, George, Fakih, Marwan
Publicado no J Clin Med (2020)

Immune profiling of microsatellite instability-high and polymerase ε (POLE)-mutated metastatic colorectal tumors identifies predictors of response to anti-PD-1 therapy

Por Wang, Chongkai, Gong, Jun, Tu, Travis Y., Lee, Peter P., Fakih, Marwan
Publicado no J Gastrointest Oncol (2018)

Guardant360 Circulating Tumor DNA Assay Is Concordant with FoundationOne Next‐Generation Sequencing in Detecting Actionable Driver Mutations in Anti‐EGFR Naive Metastatic Colorecta...

Por Gupta, Rohan, Othman, Tamer, Chen, Chen, Sandhu, Jaideep, Ouyang, Ching, Fakih, Marwan
Publicado no Oncologist (2019)

Regorafenib and Nivolumab or Pembrolizumab Combination and Circulating Tumor DNA Response Assessment in Refractory Microsatellite Stable Colorectal Cancer

Por Wang, Chongkai, Chevalier, Dawnyel, Saluja, Janelle, Sandhu, Jaideep, Lau, Cecilia, Fakih, Marwan
Publicado no Oncologist (2020)

KRAS status and clinical outcome in metastatic colorectal cancer patients treated with first-line FOLFOX chemotherapy

Por Sharma, Neelesh, Saifo, Maher, Tamaskar, Ila R, Bhuvaneswari, Ramkumar, Mashtare, Terry, Fakih, Marwan
Publicado em 2010